Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Dec 12.
Published in final edited form as: Organometallics. 2011 Dec 12;30(23):6482–6489. doi: 10.1021/om200908c

Self-assembly of Cationic, Hetero- or Homo-nuclear Ru(II) Macrocyclic Rectangles and their Photophysical, Electrochemical and Biological Studies

Vaishali Vajpayee , Young Ho Song , Yoon Jung Yang , Se Chan Kang ‡,*, Timothy R Cook ζ, Dong Wook Kim ±, Myoung Soo Lah ±, In Su Kim , Ming Wang ζ, Peter J Stang ζ,*, Ki-Whan Chi †,*
PMCID: PMC3238491  NIHMSID: NIHMS338942  PMID: 22180698

Abstract

A series of supramolecular rectangles, including two mixed-metal Ru/Pt complexes, have been formed by the coordination-driven self-assembly of a range of arene-Ru “molecular clip” acceptors (1a-1d) with rigid dipyridyl-based ligands (2a-2d) over the course of 10 hours in solution. The isolated products were characterized by multinuclear NMR (1H and 13C or 31P), HR-ESI-MS and an X-ray diffraction study to support the ascribed two-component rectangular structures. The rectangles were further characterized by UV-Vis and fluorescence studies. The redox behaviors of rectangles 3ca and 3da were also determined using cyclic voltammetry. Additionally, the antitumor activities of the suite of rectangles were determined against various human cancer cell lines and significant activity was shown by complexes 3ca, 3da, 3cb, 3cc and 3cd, with IC50 values as low as 2.65 μM.

Introduction

Coordination-drive self-assembly is an efficient method to generate supramolecules of a range of shapes and sizes, as evidenced by over two decades of work detailing the formation of squares, triangles, prisms and other 2D and 3D topologies.1 The synthetic ease and versatility of coordination-driven self-assembly complements the inherent host-guest properties afforded by the nanoscopic voids of the structures, resulting in numerous functional materials which act as sensors, molecular flasks and catalysts.2-4 While Pd(II) and Pt(II)-based architectures dominate the library of known complexes,5 the principles and strategies underlying their formation have more recently been applied to incorporate different metal ions. 6 Arene-capped octahedral metal centers are particularly useful in the formation of “molecular clips,” which are well-suited for the directional bonding strategy to form rectangles, and prisms. As such, variety of Ru, Rh, Os or Ir sandwich complex molecular clips have been utilized for the construction of various 2D and 3D-supramolecules.7 Supramolecular rectangles are the simplest of these assemblies, requiring only a 1:1 mixture of clip and linear donor. Although simple in design, these structures have shown promising applications as anion sensors and hosts for small molecules.8 These rectangles typically incorporate a single type of metal ion. However, a second metal can be introduced into the donor component of the self-assembly, potentially imparting unique or enhanced functionalities in the form of mixed-metal, heterometallic scaffolds.

More recently, the biological activity of Ru ions has prompted the synthesis and screening of a number of complexes for their antitumor properties. These studies indicate that Ru-based drugs may provide low non-specific toxicities while maintaining high efficacies relative to platinum-based agents.9 The mechanism of action of arene-Ru complexes is an active area of study, with evidence that iron mimicking (for eg. when binding with biomolecules) is an important factor.10 Since these complexes act along a different vector, cell lines which have developed Pt drug resistance remain susceptible to Ru-based treatments.11 While activity has been seen for small, mononuclear Ru complexes, studies have shown selective cellular uptake and retention of macromolecules inside cancer cells owing to damaged lymphatic drainage.12 In this context, various nano-prisms have been prepared and initial studies show high cytotoxicity against various human cancer cell lines.13 We have recently reported the preparation of a series of arene Ru-based rectangles which exhibit significant cytotoxicity against several cancer cell lines.14 The results suggested that larger metalla-cycles show higher activity over small rectangles, in agreement with the hypothesis that large macromolecules are retained inside cancer cells.

Herein, we report two heterometallic hexanuclear metalla-rectangles which self-assemble upon mixing an arene-Ru acceptor (1c, 1d) with trans-[(4-pyridylethynyl)2Pt(PEt3)2] (2a) (Scheme 1). This heterometallic rectangle is of special interest for anticancer studies as it possesses two metals ions known to be biologically active. In addition to these heterometallic constructs, a suite of homometallic tetranuclear rectangles are also reported, formed by mixing arene-Ru acceptors 1a-c with one of three dipyridyl donors, 1,4-di(pyridine-4-yl)buta-1,3-diyne (2b), 1,4-di(pyridi-4-yl)benzene (2c) and 1,2-di(pyridine-4-yl)ethyne (2d) (Scheme 1). The compound numbering used here represents the arene-Ru acceptors as 1a-d, the dipyridyl donors as 2a-d, and the resulting self-assemblies as 3xy where x refers to the acceptor and y refers to the donor components used. In all cases, two dinuclear Ru precursors react with two dipyridyl ligands, displacing the triflate ligands to yield 4+ triflate salts. The dipyridyl ligands bridge between two Ru acceptors, defining the width of the rectangle, with the height determined by the specific arene-Ru compound used.

Scheme 1.

Scheme 1

Synthetic route to the hetero- and homometallic molecular- rectangles. 1a-d denote arene-Ru acceptors, 2a-d denote dipyridyl donors, 3xy denote metalla-rectangles where x refers to the acceptor and y refers to the donor components used.

Experimental

Material and methods

The chloride analogues of arene-ruthenium acceptors 1a-1d8c,11a,11b, their triflate derivatives 8c and the donors 2a-2d1j were prepared according to literature methods. Deuterated solvents were purchased from Cambridge Isotope Laboratory (Andover, MA). NMR spectra were recorded on a Bruker 300 MHz spectrometer. 1H, 13C and 31P NMR chemical shifts are reported relative to residual solvent (H and C) and H3PO4 (P) signals. HR-ESI-Mass spectra were recorded on a Micromass Quattro II triple-quadrupole mass-spectrometer using electrospray ionization and analyzed using the MassLynx software suite. UV-Vis spectra were recorded on Cary 100 Conc. Fluorescence titration studies were carried out on a HORIBA FluoroMax-4 fluorometer. Cyclic valtametry experiments were carried out on Metrohm Autolab B. V.

Cyclic voltammetry

Cyclic voltammetry experiments were carried out with a Metrohm Autolab B. V. potentiostat at room temperature using a 3-electrode cell with platinum disk electrode (AUTOLAB RDE; 3 mm diameter) as the working electrode, platinum sheet auxiliary electrode, and calomel reference electrode. The analyzed compounds were dissolved in dichloromethane (analytical grade) to give a solution containing 5 ×10-4 M of the analytes [chloride analogues of arene-ruthenium acceptors (1c and 1d) and heteronuclear metalla-rectangles (3ca and 3da)] and 0.1MBu4NPF6. The redox potentials are given relative to the ferrocene/ ferrocenium reference.

X-ray Structure Determination

A crystal of 3ab was coated with paratone oil and affixed to a loop. Diffraction data was collected at 193 K with Mo Kα radiation using an X-ray diffraction camera system with an imaging plate equipped with a graphite crystal incident beam monochromator. The RapidAuto software suite15 was used for data collection and processing. The structure was solved by direct methods and refined by a full-matrix least-squares calculation with the SHELXTL software package.16 One dipyridyl ligand, one oxalate, two ruthenium atoms, two p-cymene ligands and one triflate anion were observed as an asymmetric unit. The other triflate anion was partially identified in the difference Fourier map. The subsequent least-squares refinement on the model containing the partially-identified atoms did not reveal the remaining part of the triflate anion. All non-hydrogen atoms were refined anisotropically; the hydrogen atoms attached to the ligands were assigned isotropic displacement coefficients U(H) = 1.2U (C) and 1.5U (Cmethyl), and their coordinates were allowed to ride on their respective atoms. The least-squares refinement of the structural model was performed under the geometry constraint AFIX for phenyl and pyridyl parts of the ligand. Additional commands, specifically DFIX, ISOR, and DELU were applied to restrain 1,2 distances, restrain Uij components approximate to isotropic behavior, and enforce a rigid bond restraint, respectively. The final refinement was performed with a modification of the structure factors for the electron densities of the partially identified triflate anion and disordered solvents using the SQUEEZE option of PLATON.17 Refinement of the structure converged at a final R1 = 0.0847, wR2 = 0.2342 for 2878 reflections with I > 2σ(I); R1 = 0.1472, wR2 = 0.2698 for all 6210 reflections. The largest difference peak and hole were 1.147 and −0.677 e·Å−3, respectively.

Cancer Cell Growth Inhibition Assay (MTT assay)

Cells were routinely grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% heat inactivated foetal bovine serum (FBS), 1% penicillin streptomycin at 37 °C and 5% CO2. The cell suspensions were seeded into 96-well plates at a concentration of 5×104 cells per well (90 μL per well and 10 μL sample). MTT ((3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was prepared as a stock solution of 5 mg/mL in phosphate buffer (PBS, pH 7.2) and was filtered. 10 μL of the MTT solution was added to each well. After incubation for 4 h at 37 °C and 5% CO2, 100 μL of DMSO (dimethylsulfoxide) was added to each well for cell lysis. The plates were read by an enzyme-linked immunosorbent assay (ELISA) reader at 570 nm for absorbance density values to determine the cell viability. The percentage of surviving cells was calculated from the ratio of the absorbance of treated to untreated cells. The half maximal inhibitory concentration (IC50) values for the inhibition of cell growth were determined by fitting the plot of the logarithmic percentage of surviving cells against the logarithm of the drug concentration using a linear regression function.

Stability of rectangles in DMSO

For stability studies, molecular rectangle 3ca were dissolved in DMSO and the sample was analyzed by 1H NMR spectroscopy immediately after dissolution and after 48 h (supporting information). No change observed even after 48 h, thus attesting the stability of molecular rectangle in DMSO.

General procedure for the synthesis of rectangles (3)

A solution of nitromethane/methanol (1:1, 2 mL) was added to a solid sample of the corresponding arene-ruthenium acceptors (1a-1d) and 4-dipyridyl donors (2a-2d) in 1:1 molar ratio. The mixture was stirred at room temperature for 10 hours after which the solution was concentrated and diethyl ether added to precipitate the pure rectangles.

Metalla-rectangle 3ca

Acceptor clip 1c (9.5 mg, 0.01mmol) and dipyridyl donor 2a (6.3 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3ca. Isolated yield: 87%. Anal. Calcd for C116H140F12N4O20P4Pt2Ru4S4: C, 43.74; H, 4.43; N, 1.76. Found: C, 43.60; H, 4.21; N, 1.83. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.15 (d, J = 6.0 Hz, 8H, Hα), 7.20 (s, 4H, Hnq), 7.06 (d, J = 6.0 Hz, 8H, Hβ), 5.72 (d, J = 6.0 Hz, 8H, Hcym), 5.52 (d, J = 6.0 Hz, 8H, Hcym), 2.90 (sept, 4H, CH(CH3)2), 2.14 (m, 36H, CH3, P(CH2CH3)3), 1.35 (d, J = 6.6 Hz, 24H,CH(CH3)2), 1.20 [t, 36H, P(CH2CH3)]; 13C NMR [75 MHz, CD3NO2]: δ (ppm) 171.0, 151.0, 139.0, 137.1, 127.1, 123.3, 123.2, 111.6, 103.6, 99.1, 84.0, 83.0, 30.5, 21.0, 16.0, 7.6; 31P {1H} NMR (121 MHz, CD3NO2): δ 11.83 (s); MS (ESI) for 3ca (C116H140F12N4O20P4Pt2Ru4S4): 1442.9 [M – 2OTf]2+, 912.4 [M – 3OTf]3+.

Metalla-rectangle 3da

Acceptor clip 1d (10.6 mg, 0.01 mmol) and dipyridyl donor 2a (6.3 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3da. Isolated yield: 85%. Anal. Calcd for C132H148F12N4O20P4Pt2Ru4S4: C, 46.83; H, 4.41; N, 1.66. Found: C, 46.55; H, 4.18; N, 1.59. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.74 (m, 8H, Hnd), 8.28 (d, J = 6.6 Hz, 8H, Hα), 7.94 (m, 8H, Hnd), 6.97 (d, J = 6.9 Hz, 8H, Hβ), 5.90 (d, J = 6.3 Hz, 8H, Hcym), 5.70 (d, J = 6.3 Hz, 8H, Hcym), 3.05 (sept, 4H, CH(CH3)2), 2.25 (s, 12H, CH3), 2.14 (m, 24H, P(CH2CH3)3), 1.37 (d, J = 6.9Hz, 24H,CH(CH3)2) 1.07 [t, 36H, P(CH2CH3)]; 13C NMR [75 MHz, CD3NO2]: δ (ppm) 170.6, 152.3, 140.3, 135.2, 134.1, 128.5, 128.4, 108.6, 108.5, 105.1, 100.6, 85.1, 84.0, 31.9, 22.6, 18.0, 8.9; 31P {1H} NMR (121 MHz, CD3NO2): δ 11.90 (s); MS (ESI) for 3da (C132H148F12N4O20P4Pt2Ru4S4): 1543.2 [M – 2OTf]2+, 979.3 [M – 3OTf]3+.

Metalla-rectangle 3ab

Acceptor clip 1a (8.6 mg, 0.01 mmol) and dipyridyl donor 2b (2.0 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3ab. Isolated yield: 89%. Anal. Calcd for C76H72F12N4O20Ru4S4.2H2O: C, 42.30; H, 3.55; N, 2.60. Found: C, 42.40; H, 3.35; N, 2.38. 1H NMR [300 MHz,CD3NO2]: δ (ppm) 8.08 (d, J = 6.6 Hz, 8H, Hα), 7.47 (d, J = 6.6 Hz, 8H, Hβ), 5.89 (d, J = 6.6 Hz, 8H, Hcym), 5.74 (d, J = 6.3 Hz, 8H, Hcym), 2.90 (sept, 4H, CH(CH3)2), 2.21 (s, 12H, CH3), 1.36 (d, J = 6.9 Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 172.2, 154.0, 133.6, 129.9, 104.5,99.1, 83.4, 83.1, 81.8, 81.7, 32.5, 22.4, 18.3; MS (ESI) for 3ab (C76H72F12N4O20Ru4S4): 558.4 [M – 3OTf]3+.

Metalla-rectangle 3bb

Acceptor clip 1b (9.1 mg, 0.01 mmol) and dipyridyl donor 2b (2.0 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3bb. Isolated yield: 85%. Anal. Calcd for C84H76F12N4O20Ru4S4: C, 45.40; H, 3.45; N, 2.52. Found: C, 45.13; H, 3.68; N, 2.78. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.35 (d, J = 6.6 Hz, 8H, Hα), 7.52 (d, J = 6.6 Hz, 8H, Hβ), 5.97 (d, J = 6.6 Hz, 8H, Hcym), 5.76 (d, J = 6.0 Hz, 8H, Hcym), 5.72 (s, 4H, Hbq), 2.93 (sept, 4H, CH(CH3)2), 2.23 (s, 12H, CH3), 1.36 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 185.8, 154.3, 133.4, 129.9, 105.5, 102.8,100.4, 84.8, 83.4, 81.1, 80.4, 32.6, 22.5, 18.3; MS (ESI) for 3bb (C84H76F12N4O20Ru4S4: 591.7 [M – 3OTf]3+.

Metalla-rectangle 3cb

Acceptor clip 1c (9.6 mg, 0.01 mmol) and dipyridyl donor 2b (2.0 mg, 0.01mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3cb. Isolated yield: 89%. Anal. Calcd for C92H80F12N4O20Ru4S4.2H2O: C, 46.86; H, 3.59; N, 2.38. Found: C, 46.63; H, 3.72; N, 2.04. 1H NMR [300 MHz,CD3NO2]: δ (ppm) 8.52 (dd, J = 1.2 Hz, J = 1.5 Hz, 8H, Hα), 7.45 (dd, J = 1.5 Hz, J = 1.5 Hz, 8H, Hβ), 7.22 (s, 4H, Hnq), 5.77 (d, J = 6.3 Hz, 8H, Hcym), 5.58 (d, J = 6.0 Hz, 8H, Hcym), 2.90 (sept, 4H, CH(CH3)2), 2.15 (s, 12H, CH3), 1.35 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 172.5, 153.4, 138.6, 133.1, 129.7, 112.8, 105.3, 100.8, 85.4, 84.5, 81.0, 79.8, 32.1, 22.7, 17.4; MS (ESI) for 3cb (C92H80F12N4O20Ru4S4): 625.1 [M – 3OTf]3+.

Metalla-rectangle 3ac

Acceptor clip 1a (8.6 mg, 0.01 mmol) and dipyridyl donor 2c (2.3 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3ac. Isolated yield: 88%. Anal. Calcd for C80H80F12N4O20Ru4S4.2H2O: C, 43.40; H, 3.82; N, 2.53. Found: C, 43.02; H, 3.91; N, 2.43. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.08 (d, J = 6.6 Hz, 8H, Hα), 7.63 (s, 8H, Hbz), 7.63 (d, J = 6.6 Hz, 8H, Hβ), 5.90 (d, J = 6.6 Hz, 8H, Hcym), 5.73 (d, J = 6.3 Hz, 8H, Hcym), 2.92 (sept, 4H, CH(CH3)2), 2.21 (s, 12H, CH3), 1.38 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 172.41, 153.98, 150.85, 137.90, 129.34, 124.57, 104.33, 99.02, 83.42, 82.85, 32.48, 22.47, 18.30 ; MS (ESI) for 3ac (C80H80F12N4O20Ru4S4): 577.1 [M – 3OTf]3+.

Metalla-rectangle 3bc

Acceptor clip 1b (9.1 mg, 0.01 mmol) and dipyridyl donor 2c (2.3 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3bc. Isolated yield: 87%. Anal. Calcd for C88H84F12N4O20Ru4S4: C, 46.39; H, 3.72; N, 2.46. Found: C, 46.21; H, 3.94; N, 2.51.. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.36 (d, J = 6.6 Hz, 8H, Hα), 7.78 (s, 8H, Hbz), 7.73 (d, J = 6.6 Hz, 8H, Hβ), 5.99 (d, J = 6.3 Hz, 8H, Hcym), 5.83 (s, 4H, Hbq), 5.77 (d, J = 6.3 Hz, 8H, Hcym), 2.96 (sept, 4H, CH(CH3)2), 2.20 (s, 12H, CH3), 1.38 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 185.81, 154.44, 150.82, 138.42, 129.31, 124.56, 105.42, 102.76, 100.20, 84.74, 83.21, 32.58, 22.50, 18.33; MS (ESI) for 3bc (C88H84F12N4O20Ru4S4): 610.4 [M – 3OTf]3+.

Metalla-rectangle 3cc

Acceptor clip 1c (9.6 mg, 0.01 mmol) and dipyridyl donor 2c (2.3 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3cc. Isolated yield: 90%. Anal. Calcd for C98H88F12N4O20Ru4S4: C, 48.48; H, 3.73; N, 2.36. Found: C, 48.20; H, 3.89; N, 2.59. 1H NMR [300 MHz,CD3NO2]: δ (ppm) 8.52 (d, J = 6.6 Hz, 8H, Hα), 7.70 (s, 8H, Hbz), 7.65 (d, J = 6.6 Hz, 8H, Hβ), 7.27 (s, 8H, Hnq), 5.79 (d, J = 6.0 Hz, 8H, Hcym), 5.59 (d, J = 6.3 Hz, 8H, Hcym), 2.95 (sept, 4H, CH(CH3)2), 2.16 (s, 12H, CH3), 1.37 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 172.79, 153.94, 151.04, 138.87, 129.30, 124.66, 112.77, 105.24, 100.89, 85.81, 84.65, 32.18, 22.43, 17.68; MS (ESI) for 3cc (C98H88F12N4O20Ru4S4): 643.7 [M – 3OTf]3+.

Metalla-rectangle 3ad

Acceptor clip 1a (8.6 mg, 0.01 mmol) and dipyridyl donor 2d (1.8 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3ad. Isolated yield: 90%. Anal. Calcd for C72H72F12N4O20Ru4S4.2H2O: C, 40.99; H, 3.63; N, 2.66. Found: C, 40.65; H, 3.78; N, 2.71. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.09, (dd, J = 1.2 Hz, J = 1.2 Hz, 8H, Hα), 7.52 (d, J = 1.5 Hz, J = 1.2 Hz, 8H, Hβ), 5.89 (d, J = 6.3 Hz, 8H, Hcym), 5.74 (d, J = 6.3 Hz, 8H, Hcym), 2.90 (sept, 4H, CH(CH3)2), 2.17 (s, 12H, CH3), 1.36 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 172.34, 153.99, 134.30, 129.63, 104.43, 99.06, 94.2, 83.38, 83.12, 32.47, 22.43, 18.29; MS (ESI) for 3ad (C72H72F12N4O20Ru4S4): 1924.0 [M – OTf]1+.

Metalla-rectangle 3bd

Acceptor clip 1b (9.1 mg, 0.01 mmol) and dipyridyl donor 2d (1.8 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3bd. Isolated yield: 85%. Anal. Calcd for C80H76F12N4O20Ru4S4.2H2O: C, 43.48; H, 3.65; N, 2.54. Found: C, 43.15; H, 3.78; N, 2.58. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.36 (dd, J = 1.2 Hz, J = 1.2 Hz, 8H, Hα), 7.56 (dd, J = 1.5 Hz, J = 1.5 Hz, 8H, Hβ), 5.96 (d, J = 6.3 Hz, 8H, Hcym), 5.76 (s, 4H, Hbq), 5.75 (d, J = 6.3 Hz, 8H, Hcym), 2.93 (sept, 4H, CH(CH3)2), 2.15 (s, 12H, CH3), 1.36 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 185.92, 154.36, 133.94, 129.51, 105.82, 102.92, 100.60, 84.72, 83.42, 32.58, 22.49, 18.32; MS (ESI) for 3bd (C80H76F12N4O20Ru4S4): 575.8 [M – 3OTf]3+.

Metalla-rectangle 3cd

Acceptor clip 1c (9.6 mg, 0.01 mmol) and dipyridyl donor 2d (1.8 mg, 0.01 mmol) were stirred in nitromethane-methanol (1:1, 2 mL) to obtain 3cd. Isolated yield: 83%. Anal. Calcd for C88H80F12N4O20Ru4S4.2H2O: C, 45.75; H, 3.67; N, 2.43. Found: C, 45.36; H, 3.72; N, 2.41. 1H NMR [300 MHz, CD3NO2]: δ (ppm) 8.50 (dd, J = 1.2 Hz, J = 1.5 Hz, 8H, Hα), 746 (d, J = 1.5 Hz, J = 1.5 Hz, 8H, Hβ), 7.27 (s, 8H, Hnq), 5.76 (d, J = 6.3 Hz, 8H, Hcym), 5.56 (d, J = 6.3 Hz, 8H, Hcym), 2.92 (sept, 4H, CH(CH3)2), 2.15 (s, 12H, CH3), 1.35 (d, J = 6.9Hz, 24H,CH(CH3)2); 13C NMR [75 MHz, CD3NO2]: δ (ppm) 172.44, 153.58, 138.67, 133.79, 129.17, 112.81, 105.42, 100.80, 93.01, 85.41, 84.51, 31.95, 22.41, 17.40; MS (ESI) for 3cd (C88H80F12N4O20Ru4S4): 2124.98 [M –OTf]1+, 984.01 [M – 2OTf]2+.

Results and Discussion

Synthesis and characterization of heterometallic and homometallic molecular rectangles

The two heterometallic rectangles form upon mixing arene–Ru acceptors 1c and 1d with the Pt-based donor (2a) in CH3NO2/MeOH solution for 10 hours at room temperature (Scheme 1). Precipitation with diethyl ether furnishes 3ca and 3da as analytically pure solids. Similarly, the homometallic rectangles also self-assemble upon mixing in CH3NO2/MeOH solution. Arene-Ru acceptors 1a-1c were mixed with donors 2b-2d to generate the series of nine rectangles, 3ab-3cb, 3ac-3cc, 3ad-3cd.

The 1H NMR spectra of 3ca and 3da are similar, each displaying two doublets corresponding to the pyridyl protons with downfield shifts relative to the free pyridyl ligands. The methyl and isopropyl resonances of the p-cymene ligands and ethyl resonances of the phosphines are relatively unaffected by self-assembly; however, the aromatic protons of the p-cymene ligands shift downfield. A sharp singlet was observed at δ = 7.20 ppm for the naphthoquinone proton of 3ca and two multiplets were found at δ = 8.75 and 8.28 ppm for the naphthacenedione protons of 3da. The 31P NMR spectra of 3ca and 3da exhibit sharp singlets at δ 11.83 and 11.90 ppm, respectively, with concomitant Pt satellites, indicative of the symmetric phosphine environment about the Pt center of ligand 2a (Figure 1). These peaks are unaffected by self-assembly formation. The 1H NMR spectra of the nine homometallic rectangles similarly showed two doublets corresponding to the pyridyl protons of the ligands (see Supporting Information). These signals show downfield shifts relative to the free ligands 2b-d, due to the loss of electron density upon coordination. The p-cymene protons appear as two doublets for 3ab-3cd and the benzoquinone protons for 3bb, 3bc, 3bd and naphthoquinone protons for 3cb, 3cc and 3cd are observed as sharp singlets nearly at δ = 5.76 and 7.27 ppm, respectively.

Figure 1.

Figure 1

31P NMR spectra of donor 2a (a) and heterometallic-rectangles 3ca (b) and 3da (c).

Electrospray ionization mass spectrometry (ESI-MS) provided further evidence for the formation of rectangles. For the heterometallic rectangles, the ESI mass spectra showed peaks at m/z = 1443.2 and 912.4 (for 3ca) and 1543.7 and 979.3 (for 3da), corresponding to the consecutive loss of the triflate anions [M-2CF3SO3]2+ and [M-3CF3SO3]3+. The peaks were isotopically resolved and matched well with their corresponding theoretical distribution patterns (see Supporting Information). The homometallic rectangles also provided prominent peaks in their HR-ESI-MS spectra. Peaks were observed for 3ab at m/z = 558.4 [3ab - 3O3SCF3-]3+; for 3bb at m/z = 591.7 [3bb - 3O3SCF3-]3+; for 3cb at m/z = 625.1 [3cb -3O3SCF3-]3+; for 3ac at m/z = 557.1 [3ac - 3O3SCF3-]3+; for 3bc at m/z = 610.4 [3bc - 3O3SCF3-]3+; for 3cc at m/z = 643.7 [3cc -3O3SCF3-]3+; 3ad at m/z = 1925.0 [3ad - O3SCF3-]1+; for 3bd at m/z = 575.8 [3bd - 3O3SCF3-]3+; for 3cd at m/z = 989.01 [3cd -2O3SCF3-]2+; for 2124.98 [3cd - O3SCF3-]1+, consistent with the formation of [2 + 2] metalla-rectangles. These observed peaks were isotopically resolved and agreed well with their theoretical isotopic distributions (see Supporting Information).

Single crystals suitable for X-ray diffraction experiments were grown of rectangle 3ab by the slow diffusion of diethyl ether into a CH3NO2/MeOH solution of the isolated product.

The structure of 3ab (selected bond lengths are summarized in Table 1) approximates a dumbbell-shape with a distance of ~24 Å between the symmetry related methyl groups of the arene ligands (generated from the inversion center, the “diagonal” of the rectangle). The ethynyl moieties of the two dipyridyl donors are bowed inward, with a spacing of ~3.32 Å (C9 – C16; Figure 2) through the center of the rectangle. This close contact suggests intramolecular π-π interactions between the pyridyl donors.

Table 1.

Bond lengths [Å] and angles [°] for 3ab.

Ru(1)-O(2) 2.05(9) Ru(1)-O(1) 2.08(8)
Ru(1)-N(1) 2.12(5) Ru(1)-C(17) 2.16(5)
Ru(2)-O(4) #1 2.05(12) Ru(2)-N(2) 2.09(5)
Ru(2)-O(3) #1 2.12(10)
O(2)-Ru(1)-O(1) 78.8(4) O(2)-Ru(1)-N(1) 82.6(2)
O(1)-Ru(1)-N(1) 83.8(2) O(4)#1-Ru(2)-C(30) 160.2(3)
N(2)#1-Ru(2)-C(30) 114.7(3) N(2)#1-Ru(1)-C(27) 115.4(3)
O(4) #1-Ru(2)-N(2) 85.0(3) N(2)-Ru(2)-O(3) #1 85.6(3)

Figure 2.

Figure 2

(a) Numbered diagram of X-ray crystal structure of the molecular rectangle 3ab; Solvent molecules and hydrogen atoms are omitted for clarity (color codes: red = Ru, green = O, blue = N and gray = C), (b) Space-filling model of 3ab.

The photophysical properties of the hetero- and homometallic rectangles were investigated using MeOH solutions. The absorption spectra of 3ca and 3da (Figure 3, left) are similar, exhibiting high energy bands around 300-360 nm with broad, weak bands extending into the visible wavelengths, ranging from 450-750 nm. These absorption bands are ascribed to a mix of metal-to-ligand (MLCT) or intramolecular charge transfer. Upon excitation at 330 nm, donor 2a and complexes 3ca and 3da are emissive, with bands at 370 and 442 nm (for 2a), 370 and 390 nm (for 3ca) and 370, 443, 525 and 560 nm (for 3da). The emission of 2a and 3ca are similar, suggesting that ligand emission dominates the spectrum of the self-assembly. Rectangle 3da exhibits significantly different emission bands, implicating that the tetracene moiety originating from acceptor 1d is responsible for the emissive properties of the self-assembly (Figure 3, right) The electronic absorbance and emission spectra of homometallic rectangles 3ab-3cd were recorded and are summarized in Table 2 (see Supporting Information for spectra). As with their heterometallic counterparts, the absorbance bands for the homometallic assemblies are ascribed to a mix MLCT and intramolecular charge transfer transitions. Upon excitation at 298 nm, the homometallic rectangles 3ab, 3bb, 3ac, 3bc, 3ad and 3bd (the oxalate and benzoquinone-spaced rectangles) showed only weak emissions, likely originating from the electron-rich donor ligands. Rectangles 3cb, 3cc and 3cd could be excited at longer wavelengths due to their more extensive absorption bands, also resulting in emission bands originating from the electron-rich donor ligands. In all cases the metalla-rectangles displayed attenuated emission intensities as compared to the donors 2b-2c, potentially due to photoinduced electron transfer from the acceptor fragments to the donor fragments, as observed for previous arene-Ru systems.4k

Figure 3.

Figure 3

UV-vis absorption (left) and emission spectra (right, the inset shows the expended view) of Pt-based donor 2a and heterometallic rectangles 3ca and 3da.

Table 2.

Photophysical properties of the metalla-rectangles.

Molecular-rectangle Absorption maxima λmax(nm) (Molar extinction co-efficient 105 ε M-1 cm-1) λex(nm) Emission maxima λmax(nm)
3ca 309 (1.09), 352(1.48), 446 (0.29), 639(0.08), 701 (0.08) 330 370, 390
3da 308 (0.86), 355 (1.19), 565 (0.14), 611 (0.18) 330 370, 443, 525, 560
3ab 303 (0.84), 323 (1.00), 337 (0.83) 298 335
3bb 316 (0.95), 358 (0.60), 494 (0.39) 298 335
3cb 323 (0.62), 353 (0.51), 437 (0.21), 643 (0.04), 701 (0.05) 330 370
3ac 312 (0.76) 298 339, 383
3bc 310 (1.25), 494 (0.41) 298 372
3cc 325 (0.61), 353 (0.50), 439 (0.21), 645 (0.05), 701 (0.04) 330 370
3ad 316 (0.48) 298 334, 352
3bd 304 (1.01), 492 (0.43) 298 357, 374
3cd 294 (0.56), 318 (0.49), 435 (0.20), 645 (0.05), 701 (0.05) 330 370

Cyclic voltammetry (CV) experiments were carried out on 1c, 1d, 3ca and 3da in dichloromethane solutions containing 0.1 M n-Bu4NPF6 as a supporting electrolyte. The redox response of 1c shows an irreversible wave at –1.25 V vs SCE, corresponding to a reduction event. Similarly, 1d exhibits an onset of cathodic current at –1.34 V; however, this reduction appears to be reversible at a scan rate of 250 mV s–1. The tetracene moiety of 1d appears to be better suited to accommodate a reduction relative to naphthalene group of 1c, due to its smaller π-system. As a result, the reduction product of 1d is stable on the timescale of this CV experiment, resulting in reversible redox behavior. This reduction is likely a Ru(II)/(I) couple, stabilized by molecular orbital contributions from the bridging oxalate-type ligands. As such, the bridging ligands play a role in stabilizing the reduction products and ultimately in determining the reversibility of the waves.

The redox behaviors of 3ca and 3da are markedly different than their corresponding arene-Ru precursors, each showing two dominant reduction events, albeit at different potentials. 3ca is reduced at –0.95 and –1.35 V, with each reduction appearing reversible across a variety of scan rates between 100 and 250 mV s–1. The redox waves of 3da are shifted relative to 3ca, with reductions occurring at –1.35 and –1.70 V. These peaks appear quasi-reversible over a range of scan rates (100 – 250 mV s–1), and may have been affected by an onset of cathodic current as the electrode approached –2.0 V, leading to some decomposition. Since the arene-Ru donors did not show two reversible waves, it is likely that this new reduction event is due to the larger π-system introduced by the Pt-diethynyldipyridyl moieties found in 2a. With the more extensive orbital manifold associated with self-assembly formation, a second electron can be accommodated and the resulting complexes are stable over the course of the experiments. Since a strong pyridyl donor is expected to increase the energy of the empty eg set of the low-spin Ru(II) complexes, the reductions at –1.35 and –1.70 V most likely correspond to the waves observed in 1c and 1d shifted to more negative potentials, as the Ru centers should be less susceptible to reduction in the presence of strong donors. The first reduction events can then be assigned as originating from the donor fragments. It is unlikely that the Pt(II) centers are so easily reduced, but the extensive π* system involving the ethynyl groups may be the source of the observed waves.

In Vitro Anticancer Activity

The in vitro cytotoxicities of the entire suite of hetero- and homometallic rectangles were explored using SK-hep-1 (liver cancer), HeLa (ovary cancer), HCT-15 (colon cancer) and AGS (gastric cancer) human cancer cell lines (Table 3). These cell lines were exposed to increasing concentrations of the metalla-rectangles for 24 h after which a colorimetric MTT assay was performed. These results were compared with the well-known antitumor drugs, cisplatin and doxorubicin. Metalla-rectangles 3ab, 3bb, 3ac, 3bc, 3ad and 3bd (the oxalate and benzoquinone-bridged arene-Ru complexes) did not show significant antitumor activity. However, the comparatively larger metalla-rectangles 3ca, 3da (containing the Pt ligand), 3cb, 3cc and 3cd (the naphthoquinone-bridged arene-Ru) exhibited low micromolar inhibition against all cancer cell lines. The growth inhibition efficacy increased with increasing cavity size and conjugation, and the highest inhibition activity was found for the heterometallic rectangles (Figure 6). In particular, the growth inhibition efficacy of metalla-rectangle 3ca was higher for all four classes of cancer cells, exceeding that of cisplatin and on the order of doxorubicin.

Table 3.

Cytotoxicity of the complexes in human cancer cells.

Metalla-rectangle IC50 μM[a]
SK-hep-1 HeLa HCT-15 AGS
3ca 5.36±0.38 9.40±0.51 9.83±0.33 2.65±0.02
3da 8.60±0.65 9.55±0.87 13.27±0.03 10.83±0.30
3ab 51.08±0.95 14.91±0.59 11.40±0.15 9.61±0.55
3bb 58.88±0.08 43.74±2.08 11.91±0.10 10.37±0.69
3cb 15.45±0.95 20.48±2.70 15.23±0.87 11.65±0.16
3ac >200 >200 >200 >200
3bc >200 >200 >200 >200
3cc 19.00±4.99 - 31.74±0.25 -
3ad >200 >200- >200 >200
3bd >200 >200 >200 >200
3cd 114.05±2.69 - 109.60±5.49 31.96±2.25
2a >200 >200 >200 >200
2b >200 >200 >200 >200
2c >200 >200 >200 147.0±7.54
2d 178.60±10.05 >200 >200 >200
Cisplatin 12.38±0.24 76.85±0.41 8.38±2.31 >100
Doxorubicin 2.67±0.24 3.16±0.04 15.34±0.58 0.70±0.16
[a]

IC50: drug concentration necessary for 50% inhibition of cell viability.

Figure 6.

Figure 6

Comparison of antitumor activity of metalla-rectangles (3ca, 3cb, 3cc and 3cd), cisplatin and doxorubicin against SK-hep-1 and HCT-15 human cancer cell lines.

The growth inhibitory activity data suggest that rectangles possessing large cavity sizes have high antitumor activity with the mixed-metal rectangles containing both Ru and Pt showing the highest activity. While the mechanisms of action of arene-Ru-based complexes are currently poorly understood, it is clear that these complexes have different mechanisms of action than cisplatin; the Ru metallacycles are active against HeLa and AGS cancer cell lines whereas cisplatin showed poor cytotoxicity. Previous studies also indicate that cisplatin and arene-Ru derivatives have different modes of action on cell-cycle regulation. During apoptosis, arene-Ru derivatives arrest the cell cycle in G1-phase,11b whereas cisplatin affects cancer cells during the G2-phase.18 Also extended conjugation and increased nuclearity appears to have an impact on the activity of the metallacyclic complexes towards cancer cell lines, as reflecting from the lowest IC50 values of 3ca and 3da.

Conclusion

In conclusion, we have described the synthesis and characterization of a suite of hetero- and homo-metallic rectangles which self-assemble from mixtures of arene-Ru based acceptors and 4-dipyridyl donors. These rectangles were characterized by multinuclear NMR (1H and 13C or 31P NMR), HR-ESI-MS analysis. The solid state structure of 3ab was determined by a single crystal X-ray diffraction study, confirming the rectangular structure assigned to these complexes. The absorbance and fluorescence properties for all metalla-rectangles were measured, indicating MLCT and intramolecular charge transfer absorption bands tailing far into the visible region, and emission bands arising from the donor and acceptor fragments. The electrochemical behaviour for the heterometallic rectangles has been studied. The arene-Ru acceptors show reduction events assigned to the Ru(II)/Ru(I) couple, stabilized by the bridging naphthalene or tetracene-based ligands. The more stabilizing tetracene ligand imparts reversibility to 1d, while the reduction of 1c is irreversible. Upon self-assembly formation, the resulting rectangles (3ca and 3da) both exhibit two reduction waves. One wave is ascribed to Ru reduction, as observed in the precursors, with the other arising from the incorporation of the Pt-diethynyl-dipyridyl ligands. Both waves have a large degree of reversibility for both complexes; however, the return current for 3da is slightly attenuated. The anti-tumor activities of the rectangles were evaluated against SK-hep-1, HeLa, HCT-15 and AGS human cancer cell lines. Preliminary results indicate that the larger metalla-rectangles possessed comparative high antitumor activity, on the order of that of cisplatin and doxorubicin. A detailed study on the mode of action as well as cellular uptake of metalla-rectangles is underway.

Supplementary Material

1_si_002
2_si_003

Figure 4.

Figure 4

Cyclic voltammograms of 1c and 1d (0.5 mM in CH2Cl2 at Pt-disk) at a scan rate 250 mV s-1.

Figure 5.

Figure 5

Cyclic voltammograms of 0.5 mM of 3ca and 3da at a scan rate of 100-250 mV s-1.

Acknowledgment

This work was supported by the World Class University (WCU) program (R33-2008-000-10003) and Priority Research Centers program (2009-0093818) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology. P. J. S. thanks the NIH (GM-57052) for financial support.

Footnotes

Supporting Information Available: 1H, 13C NMR and HR-ESI-MS spectra for metalla-rectangles 3, UV-visible and fluorescence spectra of homometallic rectangles, crystallographic data for the metalla-rectangles 3ab. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.a Lehn JM. Science. 1985;227:849–856. doi: 10.1126/science.227.4689.849. [DOI] [PubMed] [Google Scholar]; b Lehn JM. Angew. Chem. 1990;102:1347–1362. [Google Scholar]; c Stang PJ, Olenyuk B. Acc. Chem. Res. 1997;30:502–518. [Google Scholar]; d Leininger S, Olenyuk B, Stang PJ. Chem. Rev. 2000;100:853–908. doi: 10.1021/cr9601324. [DOI] [PubMed] [Google Scholar]; e Seidel SR, Stang PJ. Acc. Chem. Res. 2002;35:972–983. doi: 10.1021/ar010142d. [DOI] [PubMed] [Google Scholar]; f Jones CJ. Chem. Soc. Rev. 1998;27:289–299. [Google Scholar]; g Holliday BJ, Mirkin CA. Angew. Chem., Int. Ed. 2001;40:2022–2043. [PubMed] [Google Scholar]; h Oliver CG, Ulman PA, Wiester MJ, Mirkin CA. Acc. Chem. Res. 2008;41:1618–1629. doi: 10.1021/ar800025w. [DOI] [PMC free article] [PubMed] [Google Scholar]; i Chakrabarty R, Mukherjee PS, Stang PJ. Chem. Rev. 2011 doi: 10.1021/cr200077m. dx.doi.org/10.1021/cr200077m. [DOI] [PMC free article] [PubMed] [Google Scholar]; j Lehn J-M. Supramolecular Chemistry, Concepts and Perspectives. VCH; New York: 1995. [Google Scholar]; k Nehete UN, Anantharaman G, Chandrasekhar V, Murugavel R, Roesky HW, Vidovic D, Magull J, Samwer K, Sass BJ. Angew. Chem., Int. Ed. 2004;43:3832–3835. doi: 10.1002/anie.200453740. [DOI] [PubMed] [Google Scholar]; l Badjic JD, Nelson A, Cantrill SJ, Turnbull WB, Stoddart JF. Acc. Chem. Res. 2005;38:723–732. doi: 10.1021/ar040223k. [DOI] [PubMed] [Google Scholar]; m Dash BP, Satapathy R, Maguire JA, Hosmane NS. Org. Lett. 2008;10:2247–2250. doi: 10.1021/ol8005248. [DOI] [PubMed] [Google Scholar]; n Nitschke JR. Acc. Chem. Res. 2007;40:103–112. doi: 10.1021/ar068185n. [DOI] [PubMed] [Google Scholar]
  • 2.a Fujita M, Tominaga M, Hori A, Therrien B. Acc. Chem. Res. 2005;38:369–378. doi: 10.1021/ar040153h. [DOI] [PubMed] [Google Scholar]; b Fujita M. Chem. Soc. Rev. 1998;27:417–425. [Google Scholar]; c Rang A, Engeser M, Maier NM, Nieger M, Lindner W, Schalley CA. Chem. Eur. J. 2008;14:3855–3859. doi: 10.1002/chem.200800113. [DOI] [PubMed] [Google Scholar]; d Peinador C, Pía E, Blanco V, García MD, Quintela JM. Org. Lett. 2010;12:1380–1383. doi: 10.1021/ol1004577. [DOI] [PubMed] [Google Scholar]; e Zheng YR, Yang HB, Northrop BH, Ghosh K, Stang PJ. Inorg. Chem. 2008;47:4706–4711. doi: 10.1021/ic800038j. [DOI] [PubMed] [Google Scholar]; f Stang PJ, Olenyuk B, Fan J, Arif AM. Organometallics. 1996;15:904–908. [Google Scholar]; g Stang PJ, Chen K, Arif AM. J. Am. Chem. Soc. 1995;117:6273–6283. [Google Scholar]; h Schweiger M, Seidel R, Arif AM, Stang PJ. Inorg. Chem. 2002;41:2556–2559. doi: 10.1021/ic0112692. [DOI] [PubMed] [Google Scholar]; i Fujita M, Sasaki O, Mitsuhashi T, Fujita T, Yazaki J, Yamaguchi K, Ogura K. Chem. Commun. 1996:1535–1536. [Google Scholar]; j Das N, Ghosh A, Singh OM, Stang PJ. Org. Lett. 2006;8:1701–1704. doi: 10.1021/ol060365+. [DOI] [PubMed] [Google Scholar]; k Ghosh S, Chakrabarty R, Mukherjee PS. Inorg. Chem. 2009;48:549–556. doi: 10.1021/ic801381p. [DOI] [PubMed] [Google Scholar]; l Bar AK, Chakrabarty R, Mostafa G, Mukherjee PS. Angew. Chem., Int. Ed. 2008;47:8455–8459. doi: 10.1002/anie.200803543. [DOI] [PubMed] [Google Scholar]; m Kawamichi T, Kodama T, Kawano M, Fujita M. Angew. Chem., Int. Ed. 2008;47:8030–8032. doi: 10.1002/anie.200802545. [DOI] [PubMed] [Google Scholar]; n Jude H, Disteldorf H, Fischer S, Wedge T, Hawkridge AM, Arif AM, Hawthorne MF, Muddiman DC, Stang PJ. J. Am. Chem. Soc. 2005;127:12131–12139. doi: 10.1021/ja053050i. [DOI] [PubMed] [Google Scholar]; o Whiteford JA, Stang PJ, Huang SD. Inorg. Chem. 1998;37:5595–5601. doi: 10.1021/ic980727c. [DOI] [PubMed] [Google Scholar]; p Schnebeck RD, Randaccio L, Zangrando E, Lippert P. Angew. Chem., Int. Ed. 1998;37:119–121. [Google Scholar]; q Fan J, Whiteford JA, Olenyuk B, Levin MD, Stang PJ. J. Am. Chem. Soc. 1999;121:2741–2752. [Google Scholar]; r Drain CM, Lehn JMJ. Chem. Soc., Chem. Commun. 1994:2313–2315. [Google Scholar]; s Ikeda A, Udzu H, Zhong Z, Shinkai S, Sakamoto S, Yamaguchi K. J. Am. Chem. Soc. 2001;123:3872–3877. doi: 10.1021/ja003269r. [DOI] [PubMed] [Google Scholar]
  • 3.a Hou J–L, Ajami D, Rebek J., Jr. J. Am. Chem. Soc. 2008;130:7810–7811. doi: 10.1021/ja802288k. [DOI] [PubMed] [Google Scholar]; b Yoshizawa M, Klosterman JK, Fujita M. Angew. Chem., Int. Ed. 2009;48:3418–3438. doi: 10.1002/anie.200805340. [DOI] [PubMed] [Google Scholar]; c Caulder DL, Powers RE, Parac TN, Raymond KN. Angew. Chem., Int. Ed. 1998;37:1840–1842. [Google Scholar]; d Umemoto K, Yamaguchi K, Fujita M. J. Am. Chem. Soc. 2000;122:7150–7151. [Google Scholar]; e Kishi N, Li Z, Yoza K, Akita M, Yoshizawa M. J. Am. Chem. Soc. 2011;133:11438–11441. doi: 10.1021/ja2037029. [DOI] [PubMed] [Google Scholar]; f Fujita M, Aoyagi M, Ibukuro F, Ogura K, Yamaguchi K. J. Am. Chem. Soc. 1998;120:611–612. [Google Scholar]
  • 4.a Yao L-Y, Qin L, Xie T-Z, Li Y-Z, Yu S-Y. Inorg. Chem. 2011;50:6055–6062. doi: 10.1021/ic200047t. [DOI] [PubMed] [Google Scholar]; b Bondy CR, Gale PA, Loeb SJ. J. Am. Chem. Soc. 2004;126:5030–5031. doi: 10.1021/ja039712q. [DOI] [PubMed] [Google Scholar]; c Vega IED, Gale PA, Light ME, Loeb SJ. Chem. Commun. 2005:4913–4915. doi: 10.1039/b510506d. [DOI] [PubMed] [Google Scholar]; d Yu S-Y, Huang H-P, Li S-H, Jiao Q, Li Y-Z, Wu B, Sei Y, Yamguchi K, Pan YJ, Ma H-W. Inorg. Chem. 2005;44:9471–9488. doi: 10.1021/ic0509332. [DOI] [PubMed] [Google Scholar]; e Ning G-H, Yao L-Y, Liu L-X, Xie T-Z, Li Y-Z, Qin Y, Pan Y-J, Yu S-Y. Inorg. Chem. 2010;49:7783–7792. doi: 10.1021/ic100724r. [DOI] [PubMed] [Google Scholar]; f Shanmugam S, Bar AK, Chi K-W, Mukherjee PS. Organometallics. 2011;29:2971–2980. [Google Scholar]; g Qin Z, Jennings MS, Puddephatt RJ. Inorg. Chem. 2003;42:1956–1965. doi: 10.1021/ic020322z. [DOI] [PubMed] [Google Scholar]; h Sun S-S, Lees AJ. Chem. Commun. 2000:1687–1688. [Google Scholar]; i Beer PD, Szemes F, Balzani V, Sala CM, Drew MGB, Dent SW, Maestri M. J. Am. Chem. Soc. 1997;119:11864–11875. [Google Scholar]; j Qin Z, Jennings MC, Puddephatt RJ. Chem. Commun. 2002:354–355. doi: 10.1039/b110307e. [DOI] [PubMed] [Google Scholar]; k Vajpayee V, Kim H, Mishra A, Mukherjee PS, Stang PJ, Lee MH, Kim HK, Chi K-W. Dalton Trans. 2011;40:3112–3115. doi: 10.1039/c0dt01481h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.a Qin Z, Jennings MC, Puddephatt RJ. Chem. Commun. 2001:2676–2677. [Google Scholar]; b Sautter A, Schmid DG, Jung G, Wurthner F. J. Am. Chem. Soc. 2001;123:5424–5430. doi: 10.1021/ja004360y. [DOI] [PubMed] [Google Scholar]; c Schnebeck R-D, Freisinger E, Glahe F, Lippert B. J. Am. Chem. Soc. 2000;122:1381–1390. [Google Scholar]; d Hall J, Loeb SJ, Shimizu GKH, Yap GPA. Angew. Chem., Int. Ed. 1998;37:121–123. [Google Scholar]; e Goeb S, Prusakova V, Wang X, Vèzinat A, Sallè M. Chem. Commun. 2011;47:4397–4399. doi: 10.1039/c1cc10239g. [DOI] [PubMed] [Google Scholar]; f Lusby PJ, Müller P, Pike SJ, Slawin AMZ. J. Am. Chem. Soc. 2009;131:16398–16400. doi: 10.1021/ja907297z. [DOI] [PubMed] [Google Scholar]; g Ghosh S, Chakrabarty R, Mukherjee PS. Dalton Trans. 2008:1850–1856. doi: 10.1039/b713783d. [DOI] [PubMed] [Google Scholar]
  • 6.a Dinolfo PH, Williams ME, Stern CL, Hupp JT. J. Am. Chem. Soc. 2004;126:12989–13001. doi: 10.1021/ja0473182. [DOI] [PubMed] [Google Scholar]; b Benkstein KD, Hupp JT, Stern CL. Angew. Chem., Int. Ed. 2000;39:2891–2893. doi: 10.1002/1521-3773(20000818)39:16<2891::aid-anie2891>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]; c Dinolfo PH, Hupp JT. Chem. Mater. 2001;13:3113–3125. [Google Scholar]; d Yu W-B, Han Y-F, Lin Y-J, Jin G-X. Organometallics. 2010;29:2827–2830. [Google Scholar]; e Zhang W-Z, Han Y-F, Lin Y-J, Jin G-X. Dalton Trans. 2009:8426–8431. doi: 10.1039/b909357e. [DOI] [PubMed] [Google Scholar]; f Wang M, Vajpayee V, Shanmugaraju S, Zheng Y-R, Zhao Z, Kim H, Mukherjee PS, Chi K-W, Stang PJ. Inorg. Chem. 2011;50:1506–1512. doi: 10.1021/ic1020719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.a Han Y-F, Jia W-G, Yu W-B, Jin G-X. Chem. Soc. Rev. 2009:3419–3434. doi: 10.1039/b901649j. [DOI] [PubMed] [Google Scholar]; b Boyer JL, Kuhlman ML, Rauchfuss TB. Acc. Chem. Res. 2007;40:233–242. doi: 10.1021/ar050215j. [DOI] [PubMed] [Google Scholar]; c Barry NPE, Furrer J, Freudenreich J, Süss-Fink G, Therrien B. Eur. J. Inorg. Chem. 2010:725–728. [Google Scholar]; d Han Y-F, Lin Y-J, Jia W-G, Wang G-L, Jin G-X. Chem. Commun. 2008:1807–1809. doi: 10.1039/b717554j. [DOI] [PubMed] [Google Scholar]; e Mattsson J, Zava O, Renfrew AK, Sei Y, Yamaguchi K, Dyson PJ, Therrien B. Dalton Trans. 2010;39:8248–8255. doi: 10.1039/c0dt00436g. [DOI] [PubMed] [Google Scholar]; f Barry NPE, Edafe F, Dyson PJ, Therrien B. Dalton Trans. 2010;39:2816–2820. doi: 10.1039/b925015h. [DOI] [PubMed] [Google Scholar]
  • 8.a Piotrowski H, Polborn K, Hilt G, Severin K. J. Am. Chem. Soc. 2001;123:2699–2700. doi: 10.1021/ja005804t. [DOI] [PubMed] [Google Scholar]; b Han Y-F, Jia W-G, Lin Y-J, Jin G-X. Angew. Chem. Int. Ed. 2009;48:6234–6238. doi: 10.1002/anie.200805949. [DOI] [PubMed] [Google Scholar]; c Yan H, Süss-Fink G, Neels A, Stoeckli-Evans H. J. Chem. Soc. Dalton Trans. 1997:4345–4350. [Google Scholar]; d Han Y-F, Lin Y-J, Jia L-H, Weng W-G, Jin G-X. Organometallics. 2007;26:5848–5853. [Google Scholar]; e Jia W-G, Han Y-F, Lin Y-J, Weng L-H, Jin G-X. Organometallics. 2009;28:3459–3464. [Google Scholar]; f Linares F, Galindo MA, Galli S, Romero MA, Navarro JAR, Barea E. Inorg. Chem. 2009;48:7413–7420. doi: 10.1021/ic900980y. [DOI] [PubMed] [Google Scholar]; g Zhang W-Z, Han Y-F, Lin Y-J, Jin G-X. Organometallics. 2010;29:2842–2849. [Google Scholar]; h Vajpayee V, Song YH, Lee MH, Kim H, Wang M, Stang PJ, Whan K-W. Chem. Eur. J. 2011;17:7837–7844. doi: 10.1002/chem.201100242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.a Dyson PJ, Sava G. Dalton Trans. 2006:1929–1933. doi: 10.1039/b601840h. [DOI] [PubMed] [Google Scholar]; b Magennis SW, Habtemariam A, Novakova O, Henry JB, Meier S, Parsons S, Oswald IDH, Brabec V, Sadler PJ. Inorg. Chem. 2007;46:5059–5068. doi: 10.1021/ic062111q. [DOI] [PubMed] [Google Scholar]; c Yan YK, Melchart M, Habtemariam A, Sadler PJ. Chem. Commun. 2005:4764–4776. doi: 10.1039/b508531b. [DOI] [PubMed] [Google Scholar]
  • 10.Allardyce CS, Dyson PJ. Plat. Met. Rev. 2001;45:62–69. [Google Scholar]
  • 11.a Therrien B, Süss-Fink G, Govindaswamy P, Renfrew AK, Dyson PJ. Angew. Chem., Int. Ed. 2008;47:3773–3776. doi: 10.1002/anie.200800186. [DOI] [PubMed] [Google Scholar]; b Vajpayee V, Yang YJ, Kang SC, Kim H, Kim IS, Wang M, Stang P, Chi K-W. Chem. Commun. 2011;47:5184–5186. doi: 10.1039/c1cc10167f. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Zava O, Mattsson J, Dyson PJ, Therrien B. Chem.–Eur. J. 2010;16:1428–1431. doi: 10.1002/chem.200903216. [DOI] [PubMed] [Google Scholar]
  • 12.a Matsumura Y, Maeda H. Cancer. Res. 1986;46:6387–6392. [PubMed] [Google Scholar]; b Maeda H. Advan. Enzyme Regul. 2001;41:189–207. doi: 10.1016/s0065-2571(00)00013-3. [DOI] [PubMed] [Google Scholar]
  • 13.a Barry NPE, Zava O, Furrer J, Dyson PJ, Therrien B. Dalton Trans. 2010;39:5272–5277. doi: 10.1039/c001521k. [DOI] [PubMed] [Google Scholar]; b Pitto-Barry A, Barry NPE, Zava O, Deschenaux R, Dyson PJ. Chem.–Eur. J. 2011;17:1966–1971. doi: 10.1002/chem.201002634. [DOI] [PubMed] [Google Scholar]; c Pitto-Barry A, Barry NPE, Zava O, Deschenaux R, Therrien B. Chem. –Asian J. 2011;6:1595–1603. doi: 10.1002/asia.201100136. [DOI] [PubMed] [Google Scholar]; d Barry NPE, Zava O, Dyson PJ, Therrien B. Chem.–Eur. J. 2011;17:9669–9677. doi: 10.1002/chem.201003530. [DOI] [PubMed] [Google Scholar]
  • 14.Vajpayee V, Song YH, Yang YJ, Kang S, Kim H, Kim IS, Wang M, Stang PJ, Chi K–W. Organometallics. 2011;30:3242–3245. doi: 10.1021/om200294x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rapid Auto software . R-Axis series, Cat. No. 9220B101. Rigaku Corporation; [Google Scholar]
  • 16.Sheldrick SL. Crystal Structure Analysis Package. Bruker Analytical X-Ray; Madison, WI, USA: 1997. SHELXTL-PLUS. [Google Scholar]
  • 17.PLATON program. Spek AL. Acta Crystallogr. Sect. A. 1990;46:194. [Google Scholar]
  • 18.Kisova A, Zerzankova L, Habtemariam A, Sadler PJ, Brabec V, Kasparkova J. Mol. Pharmaceutics. 2011;8:949–957. doi: 10.1021/mp200105d. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_002
2_si_003

RESOURCES